Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

The Oldest Image of a Woman During Vaginal Delivery in the Continental Shelf of Iran.

Naser Moghadasi A.

Arch Iran Med. 2019 Oct 1;22(10):631-632. No abstract available.

2.

Burnt City and the Evolution of Cognitive Science.

Naser Moghadasi A.

Arch Iran Med. 2019 Aug 1;22(8):480-481. No abstract available.

3.

Evaluating the efficacy and safety of ZytuxTM (Rituximab, AryoGen pharmed) in Iranian multiple sclerosis patients: An observational study.

Naser Moghadasi A, Darki A, Masoumi P, Hashemi SN, Ghadiri F.

Mult Scler Relat Disord. 2019 Sep 27;36:101419. doi: 10.1016/j.msard.2019.101419. [Epub ahead of print]

PMID:
31586800
4.

The correlation between dyslipidemia and cognitive impairment in multiple sclerosis patients.

Noori H, Gheini MR, Rezaeimanesh N, Saeedi R, Rezaei Aliabadi H, Sahraian MA, Naser Moghadasi A.

Mult Scler Relat Disord. 2019 Sep 26;36:101415. doi: 10.1016/j.msard.2019.101415. [Epub ahead of print]

PMID:
31586799
5.

Aggressive course of cognitive impairment in multiple sclerosis: A new term for the management of patients.

Naser Moghadasi A, Sahraian MA.

J Clin Neurosci. 2019 Sep 5. pii: S0967-5868(19)31371-2. doi: 10.1016/j.jocn.2019.08.104. [Epub ahead of print]

PMID:
31495660
6.

Pediatric multiple sclerosis and its familial recurrence: A population based study (1999-2017).

Eskandarieh S, Sahraiain MA, Molazadeh N, Moghadasi AN.

Mult Scler Relat Disord. 2019 Aug 27;36:101377. doi: 10.1016/j.msard.2019.101377. [Epub ahead of print]

PMID:
31473489
7.

When an octopus has MS: Application of neurophysiology and immunology of octopuses for multiple sclerosis.

Naser Moghadasi A.

Med Hypotheses. 2019 Oct;131:109297. doi: 10.1016/j.mehy.2019.109297. Epub 2019 Jul 1.

PMID:
31443774
8.

Disability and Therapeutic Response in Paediatric Neuromyelitis Optica Spectrum Disorder: A Case Series from Iran.

Baghbanian SM, Sahraian MA, Naser Moghadasi A, Asgari N.

Iran J Child Neurol. 2019 Summer;13(3):99-104.

9.

Multiple sclerosis national registry system in Iran: Validity and reliability of a minimum data set.

Shahin S, Eskandarieh S, Moghadasi AN, Razazian N, Baghbanian SM, Ashtari F, Bayati A, Manouchehrinia A, Beiki O, Mohebi F, Dezfuli MM, Sahraian MA.

Mult Scler Relat Disord. 2019 Aug;33:158-161. doi: 10.1016/j.msard.2019.06.009. Epub 2019 Jun 9.

PMID:
31203146
10.

Management of seizures in patients with multiple sclerosis; an Iranian consensus.

Asadi-Pooya AA, Sahraian MA, Sina F, Baghbanian SM, Habibabadi JM, Shaygannejad V, Asadollahi M, Karvigh SA, Moghadasi AN, Nikseresht A, Motamedi M.

Epilepsy Behav. 2019 Jul;96:244-248. doi: 10.1016/j.yebeh.2019.04.032. Review.

PMID:
31151870
11.

The relationship between cognitive function and body mass index in multiple sclerosis patients.

Owji M, Ashraf-Ganjouei A, Sahraian MA, Bidadian M, Ghadiri F, Naser Moghadasi A.

Mult Scler Relat Disord. 2019 Jul;32:37-40. doi: 10.1016/j.msard.2019.04.024. Epub 2019 Apr 21.

PMID:
31030017
12.

The association between dietary sugar intake and neuromyelitis optica spectrum disorder: A case-control study.

Rezaeimanesh N, Razeghi Jahromi S, Ghorbani Z, Beladi Moghadam N, Hekmatdoost A, Naser Moghadasi A, Azimi AR, Sahraian MA.

Mult Scler Relat Disord. 2019 Jun;31:112-117. doi: 10.1016/j.msard.2019.03.028. Epub 2019 Apr 4.

PMID:
30978652
13.
14.

Progressive solitary sclerosis presented with diplopia: A case report.

Sahraian MA, Ghiasian M, Moghadasi AN, Shafaei M, Ghaffari M.

Mult Scler Relat Disord. 2019 Feb;28:129-131. doi: 10.1016/j.msard.2018.12.023. Epub 2018 Dec 18.

PMID:
30594812
15.

Autoimmune diseases associated with Neuromyelitis Optica Spectrum Disorders: A literature review.

Shahmohammadi S, Doosti R, Shahmohammadi A, Mohammadianinejad SE, Sahraian MA, Azimi AR, Harirchian MH, Asgari N, Naser Moghadasi A.

Mult Scler Relat Disord. 2019 Jan;27:350-363. doi: 10.1016/j.msard.2018.11.008. Epub 2018 Nov 16. Review.

PMID:
30476871
16.

Corpus callosum agenesis and clinically isolated syndrome (CIS): A case report.

Naser Moghadasi A.

Mult Scler Relat Disord. 2019 Jan;27:342-343. doi: 10.1016/j.msard.2018.11.017. Epub 2018 Nov 17. No abstract available.

PMID:
30472413
17.

Increased expression of mir-301a in PBMCs of patients with relapsing-remitting multiple sclerosis is associated with reduced NKRF and PIAS3 expression levels and disease activity.

Tavakolpour V, Shokri G, Naser Moghadasi A, Mozafari Nahavandi P, Hashemi M, Kouhkan F.

J Neuroimmunol. 2018 Dec 15;325:79-86. doi: 10.1016/j.jneuroim.2018.10.002. Epub 2018 Oct 4.

PMID:
30316680
18.

Thrombotic microangiopathy associated with interferon-beta treatment in patients with multiple sclerosis.

Baghbanian SM, Moghadasi AN.

Iran J Neurol. 2018 Apr 4;17(2):89-90. No abstract available.

19.

Evaluating the relationship between emotional intelligence and cognitive disorders in patients with Multiple Sclerosis.

Owji M, Sahraian MA, Bidadian M, Ghadiri F, Etesam F, Azimi A, Moghadasi AN.

Iran J Neurol. 2018 Apr 4;17(2):78-81.

20.

Evaluation of the risk of cervical cancer in patients with Multiple Sclerosis treated with cytotoxic agents: A cohort study.

Doosti R, Togha M, Moghadasi AN, Aghsaie A, Azimi AR, Khorramnia S, Moinfar Z, Ensani F, Harirchian MH, Minagar A, Sahraian MA.

Iran J Neurol. 2018 Apr 4;17(2):64-70.

21.

Therapeutic Use of Intrathecal Mesenchymal Stem Cells in patients with Multiple Sclerosis: A Pilot Study with Booster Injection.

Sahraian MA, Mohyeddin Bonab M, Baghbanian SM, Owji M, Naser Moghadasi A.

Immunol Invest. 2019 Feb;48(2):160-168. doi: 10.1080/08820139.2018.1504301. Epub 2018 Aug 29.

PMID:
30156938
22.

The prevalence, incidence and familial recurrence of multiple sclerosis in Tehran, Iran.

Eskandarieh S, Molazadeh N, Moghadasi AN, Azimi AR, Sahraian MA.

Mult Scler Relat Disord. 2018 Oct;25:143. doi: 10.1016/j.msard.2018.07.023. Epub 2018 Jul 17. No abstract available.

PMID:
30075407
23.

Pain in Patients with Multiple Sclerosis.

Ghajarzadeh M, Jalilian R, Sahraian MA, Moghadasi AN, Azimi A, Mohammadifar M, Azizi S.

Maedica (Buchar). 2018 Jun;13(2):125-130. doi: 10.26574/maedica.2018.13.2.125.

24.

Myocardial infarction in a patient with multiple sclerosis after receiving natalizumab.

Darki A, Masoumi P, Soleimani A, Naser Moghadasi A.

Mult Scler Relat Disord. 2018 Oct;25:26-28. doi: 10.1016/j.msard.2018.07.016. Epub 2018 Jul 11.

PMID:
30025371
25.

Immunomodulatory function of Treg-derived exosomes is impaired in patients with relapsing-remitting multiple sclerosis.

Azimi M, Ghabaee M, Moghadasi AN, Noorbakhsh F, Izad M.

Immunol Res. 2018 Aug;66(4):513-520. doi: 10.1007/s12026-018-9008-5.

PMID:
29882035
26.

Tumefactive demyelinating lesions in a patient with multiple sclerosis receiving natalizumab.

Moghadasi AN, Baghbanian SM.

Acta Neurol Belg. 2019 Mar;119(1):137-139. doi: 10.1007/s13760-018-0948-2. Epub 2018 Jun 6. No abstract available.

PMID:
29876751
27.

Anti-JC virus antibody sera positivity and index value among patients with multiple sclerosis may be correlated with age, sex, and area of residence.

Koolaji S, Allahabadi NS, Ahmadi A, Eskandarieh S, Moghadasi AN, Azimi AR, Sahraian MA.

J Neurovirol. 2018 Oct;24(5):570-576. doi: 10.1007/s13365-018-0646-0. Epub 2018 May 21.

PMID:
29785581
28.

A presentation of ulcerative colitis after rituximab therapy in a patient with multiple sclerosis and literature review.

Shahmohammadi S, Sahraian MA, Shahmohammadi A, Doosti R, Zare-Mirzaie A, Naser Moghadasi A.

Mult Scler Relat Disord. 2018 May;22:22-26. doi: 10.1016/j.msard.2018.02.030. Epub 2018 Mar 1. Review.

PMID:
29524758
29.

Environmental risk factors in neuromyelitis optica spectrum disorder: a case-control study.

Eskandarieh S, Nedjat S, Abdollahpour I, Azimi AR, Moghadasi AN, Asgari N, Sahraian MA.

Acta Neurol Belg. 2018 Jun;118(2):277-287. doi: 10.1007/s13760-018-0900-5. Epub 2018 Mar 2.

PMID:
29500680
30.

Convergent effects of a functional C3 variant on brain atrophy, demyelination, and cognitive impairment in multiple sclerosis.

Roostaei T, Sadaghiani S, Mashhadi R, Falahatian M, Mohamadi E, Javadian N, Nazeri A, Doosti R, Naser Moghadasi A, Owji M, Hashemi Taheri AP, Shakouri Rad A, Azimi A, Voineskos AN, Nazeri A, Sahraian MA.

Mult Scler. 2019 Apr;25(4):532-540. doi: 10.1177/1352458518760715. Epub 2018 Feb 27.

PMID:
29485352
31.

A comparison of pediatric and adult neuromyelitis optica spectrum disorders: A review of clinical manifestation, diagnosis, and treatment.

Baghbanian SM, Asgari N, Sahraian MA, Moghadasi AN.

J Neurol Sci. 2018 May 15;388:222-231. doi: 10.1016/j.jns.2018.02.028. Epub 2018 Feb 19. Review.

PMID:
29478727
32.

Neuromyelitis optica and neuromyelitis optica like spectrum disorders: Is it not the time to change the criteria?

Naser Moghadasi A.

Mult Scler Relat Disord. 2018 Feb;20:153. doi: 10.1016/j.msard.2018.01.022. Epub 2018 Mar 20. No abstract available.

PMID:
29414289
33.

Association of Limb-Girdle muscular dystrophy with multiple sclerosis: A case report.

Arzani M, Rezaei H, Moghadasi AN.

Caspian J Intern Med. 2018 Winter;9(1):96-99. doi: 10.22088/cjim.9.1.96.

34.

Combination treatment of docosahexaenoic acid (DHA) and all-trans-retinoic acid (ATRA) inhibit IL-17 and RORγt gene expression in PBMCs of patients with relapsing-remitting multiple sclerosis.

Mousavi Nasl-Khameneh A, Mirshafiey A, Naser Moghadasi A, Chahardoli R, Mahmoudi M, Parastouei K, Yekaninejad MS, Saboor-Yaraghi AA.

Neurol Res. 2018 Jan;40(1):11-17. doi: 10.1080/01616412.2017.1382800. Epub 2017 Nov 18.

PMID:
29155646
35.

Optic neuritis with radiological longitudinal spinal cord involvement and seronegative anti-aquaporin antibody: Evidence from a case study.

Naser Moghadasi A.

Mult Scler Relat Disord. 2017 Nov;18:26-28. doi: 10.1016/j.msard.2017.09.008. Epub 2017 Sep 12.

PMID:
29141816
36.

Neuromyelitis optica spectrum disorders in Iran.

Eskandarieh S, Nedjat S, Azimi AR, Moghadasi AN, Sahraian MA.

Mult Scler Relat Disord. 2017 Nov;18:209-212. doi: 10.1016/j.msard.2017.10.007. Epub 2017 Oct 9.

PMID:
29141812
37.

Diagnosis and management of Neuromyelitis Optica Spectrum Disorder (NMOSD) in Iran: A consensus guideline and recommendations.

Sahraian MA, Moghadasi AN, Azimi AR, Asgari N, H Akhoundi F, Abolfazli R, Alaie S, Ashtari F, Ayromlou H, Baghbanian SM, Moghadam NB, Fatehi F, Foroughipour M, Langroodi HG, Majdinasab N, Nickseresht A, Nourian A, Shaygannejad V, Torabi HR.

Mult Scler Relat Disord. 2017 Nov;18:144-151. doi: 10.1016/j.msard.2017.09.015. Epub 2017 Sep 25. Review.

PMID:
29141797
38.

Recurrent isolated optic neuritis: A study on 22 patients.

Arzani M, Sahraian MA, Rezaei H, Moghadasi AN.

Iran J Neurol. 2017 Jul 6;16(3):130-135.

39.

Optic neuritis in a patient with celiac disease.

Baghbanian SM, Naser Moghadasi A.

Neurol Neurochir Pol. 2017 Nov - Dec;51(6):534-536. doi: 10.1016/j.pjnns.2017.07.014. Epub 2017 Aug 1. No abstract available.

PMID:
28803640
40.

The first attack of multiple sclerosis presented immediately after voluntary and intensive weight loss: A case series.

Bitarafan S, Amani K, Sahraian MA, Sarraf P, Soltani D, Moghadasi AN, Harirchian MH.

Iran J Neurol. 2017 Jan 5;16(1):41-42. No abstract available.

41.

Clinical and Epidemiological Aspects of Multiple Sclerosis in Children.

Nasehi MM, Sahraian MA, Naser Moghadasi A, Ghofrani M, Ashtari F, Taghdiri MM, Tonekaboni SH, Karimzadeh P, Afshari M, Moosazadeh M.

Iran J Child Neurol. 2017 Spring;11(2):37-43.

42.

The expression of VDR mRNA but not NF-κB surprisingly decreased after vitamin D treatment in multiple sclerosis patients.

Shirvani-Farsani Z, Kakhki MP, Gargari BN, Doosti R, Moghadasi AN, Azimi AR, Behmanesh M.

Neurosci Lett. 2017 Jul 13;653:258-263. doi: 10.1016/j.neulet.2017.05.050. Epub 2017 May 30.

PMID:
28576565
43.

Sleep Disorder as a Triggering Factor for Relapse in Multiple Sclerosis.

Sahraian MA, Rezaali S, Hosseiny M, Doosti R, Tajik A, Naser Moghadasi A.

Eur Neurol. 2017;77(5-6):258-261. doi: 10.1159/000470904. Epub 2017 Mar 31.

PMID:
28359058
44.

Comparing epidemiology and baseline characteristic of multiple sclerosis and neuromyelitis optica: A case-control study.

Eskandarieh S, Nedjat S, Abdollahpour I, Moghadasi AN, Azimi AR, Sahraian MA.

Mult Scler Relat Disord. 2017 Feb;12:39-43. doi: 10.1016/j.msard.2017.01.004. Epub 2017 Jan 6.

PMID:
28283104
45.

Catastrophic presentation of a patient with combined NMOSD and thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a case report.

Okhovat AA, Ansari B, Rezaali S, Altintas A, Naser Moghadasi A.

Acta Neurol Belg. 2017 Sep;117(3):757-759. doi: 10.1007/s13760-016-0710-6. Epub 2016 Oct 18. No abstract available.

PMID:
27757811
46.

Bacterial meningitis in a patient with multiple sclerosis receiving Tysabri.

Moghadasi AN, Advani S, Rahimi S.

Iran J Neurol. 2016 Jul 6;15(3):175-6. No abstract available.

47.

Concomitant multiple sclerosis and another autoimmune disease: Does the clinical course change?

Sahraian MA, Owji M, Naser Moghadasi A.

Clin Neurol Neurosurg. 2016 Nov;150:92-95. doi: 10.1016/j.clineuro.2016.09.003. Epub 2016 Sep 4.

PMID:
27614222
48.

Cryptococcal meningitis in a human immunodeficiency virus-negative patient with rheumatoid arthritis.

Haghighi S, Seyed Ahadi M, Naser Moghadasi A.

Iran J Neurol. 2016 Apr 3;15(2):106-8. No abstract available.

49.

NMOSD with an unusual cerebral radiologic manifestation.

Moghadasi AN, Altintas A.

Mult Scler Relat Disord. 2016 May;7:74-5. doi: 10.1016/j.msard.2016.03.016. Epub 2016 Mar 30. No abstract available.

PMID:
27237763
50.

Headache in relapse and remission phases of multiple sclerosis: A case-control study.

Togha M, Abbasi Khoshsirat N, Moghadasi AN, Mousavinia F, Mozafari M, Neishaboury M, Mousavi SM.

Iran J Neurol. 2016 Jan 5;15(1):1-8.

Supplemental Content

Loading ...
Support Center